January 13, 2025
A new phase
While I am not attending JPM that doesn’t mean I’m clueless as to what’s happening in that beautiful city by the bay. Dexcom kicked things off this morning and as has become their nature preannounced fourth quarter results and provided guidance for 2025. Given the stock isn’t doing all that much today I’d say the analysts are pleased with what they heard. Me I could actually care less as I am not looking at what’s happening today but looking towards the future.
While everyone is fumbling about concentrating on the next quarter, they as . . .
This content is restricted to subscribers. Please subscribe.
Already have an account? Please login.
